(Q30395173)

21 June 2017

title

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults (English)

1 reference

21 June 2017

Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults (English)

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.10.009

8 August 2024

1 reference

Lynda Tussey

3

1 reference

21 June 2017

Christine Hay

4

1 reference

21 June 2017

Carrie Nolan

5

1 reference

21 June 2017

Theresa Fitzgerald

6

1 reference

21 June 2017

Ge Liu

7

1 reference

21 June 2017

Uma Kavita

8

1 reference

21 June 2017

Langzhou Song

9

1 reference

21 June 2017

Irving Dark

10

1 reference

21 June 2017

Alan Shaw

11

1 reference

21 June 2017

John J. Treanor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969925

8 August 2024

David N. Taylor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969925

8 August 2024

language of work or name

English

0 references

publication date

20 October 2010

1 reference

full work available at URL

21 June 2017

https://api.elsevier.com/content/article/PII:S0264410X10014696?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.10.009

https://api.elsevier.com/content/article/PII:S0264410X10014696?httpAccept=text/plain

8 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.10.009

8 August 2024

1 reference

21 June 2017

volume

28

1 reference

21 June 2017

issue

52

1 reference

21 June 2017

page(s)

8268-8274

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Influenza-associated hospitalizations in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Influenza and the rates of hospitalization for respiratory disease among infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

The Number and Location of Glycans on Influenza Hemagglutinin Determine Folding and Association with Calnexin and Calreticulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Immune response to human influenza virus hemagglutinin expressed in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Regulation of phagosome maturation by signals from toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Characterization and functional investigation of single nucleotide polymorphisms (SNPs) in the human TLR5 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Importance of hemagglutinin glycosylation for the biological functions of influenza virus

8

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.10.009

8 August 2024

Identifiers

1 reference

21 June 2017

1 reference